HIGH DOSE DAUNORUBICIN (NSC-83142) IN TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA

被引：0
|
作者：
LIPPMAN, M
ZAGER, R
HENDERSON, ES
机构：
[1] NCI, DIV CANC TREATMENT, LAB HEMATOL, BETHESDA, MD 20014 USA
[2] NCI, DIV CANC TREATMENT, LAB CHEM PHARMACOL, BETHESDA, MD 20014 USA
[3] NCI, DIV CANC TREATMENT, SUPORT CARE BRANCH, BETHESDA, MD 20014 USA
[4] NCI, DIV CANC TREATMENT, CANC THERAPY EVALUATION BRANCH, BETHESDA, MD 20014 USA
来源：
CANCER CHEMOTHERAPY REPORTS PART 1 | 1972年 / 56卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：755 / 760
页数：6
相关论文
共 50 条
  • [21] Successful treatment of Aspergillus spondylodiscitis with high-dose itraconazole in a patient with acute myelogenous leukemia
    K Takagi
    A Yoshida
    T Yamauchi
    T Yamashita
    H Iwasaki
    H Tsutani
    Y Maezawa
    H Baba
    T Ueda
    Leukemia, 2001, 15 : 1670 - 1671
  • [22] HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)
    GISSLINGER, H
    PREIS, P
    LINKESCH, W
    BLUT, 1985, 51 (03): : 210 - 210
  • [23] TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA
    MORLEY, AA
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (25): : 1717 - 1717
  • [24] Daunorubicin for the treatment of acute myeloid leukemia
    Bertuzzi, Clara
    Paolini, Stefania
    Visani, Giuseppe
    Piccaluga, Pier Paolo
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (10): : 1075 - 1087
  • [25] Treatment of acute myelogenous leukemia
    Slater, S
    Rohatiner, AZS
    Murphy, M
    Amess, J
    Carter, M
    Lister, TA
    Johnson, S
    Ewings, M
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1710 - 1710
  • [26] Treatment of acute myelogenous leukemia
    Estey, EH
    ONCOLOGY-NEW YORK, 2002, 16 (03): : 343 - +
  • [27] Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine
    Sitar, Daniel S.
    Aoki, Fred Y.
    Bow, Eric J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (08): : 995 - 998
  • [28] DOSE-INTENSIVE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - IMPROVED SURVIVAL
    SCHILLER, G
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1828 - 1829
  • [29] IMMUNE CHECKPOINT EXPRESSION IN ACUTE LEUKEMIA IS INFLUENCED BY DAUNORUBICIN TREATMENT DOSE.
    Stockard, B.
    Nemechek, J.
    Schroeder, K.
    Pace, J.
    Perry, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S50 - S51
  • [30] EVALUATION OF DAUNORUBICIN (NSC-82151) AND METHOTREXATE (NSC-740) IN COMBINATION AS A REMISSION MAINTENANCE REGIMEN IN TREATMENT OF ACUTE-LEUKEMIA
    HUMPHREY, GB
    FERNBACH, DJ
    RAZEK, AA
    STUCKEY, WJ
    KOMP, D
    GEORGE, S
    CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (02): : 395 - 399
12345